Influence of active awareness about venous thromboembolism relevance and rate of symptomatic deep vein thrombosis

ISRCTN ISRCTN27831914
DOI https://doi.org/10.1186/ISRCTN27831914
Secondary identifying numbers DIREG L 03049
Submission date
12/01/2012
Registration date
31/01/2012
Last edited
25/05/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Deep vein thrombosis (DVT) is a blood clot that develops within a deep vein in the body, usually in the leg, causing cause pain and swelling. The symptoms of DVT are not specific - patients can have large clots but only minimal symptoms which, if disregarded, can result in dangerous consequences including sudden death. However, most DVT patients have a good outcome. An increase in public awareness of DVT and its symptoms may in time reduce the overall disease burden. Although there have been many attempts to raise public awareness about DVT, their effects are not known. The aim of this study is to find out whether an increase in public awareness results in more people being correctly diagnosed with DVT.

Who can participate?
Patients aged over 18 with symptoms suggesting DVT

What does the study involve?
A campaign to raise public awareness of DVT is conducted in an urban area, with brochures being distributed four times during a year and posters and newsletter articles being published. This area is compared with another area that is not exposed to the campaign. Patients with symptoms of DVT in both areas are referred by their GPs for an ultrasound scan of their leg at no charge to the patient. The impact of the educational campaign on the number of patients correctly diagnosed DVT is assessed.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
Institute of Tuberculosis and Lung Diseases (Instytut Gruzlicy i Chorob Pluc) (Poland)

When is the study starting and how long is it expected to run for?
December 2007 to November 2009

Who is funding the study?
Sanofi-Aventis (Poland)

Who is the main contact?
Prof. Witold Tomkowski

Contact information

Prof Witold Tomkowski
Scientific

Instytut Gruzlicy i Chorob Pluc
Plocka Str. 26
Warsaw
01-138
Poland

Study information

Study designMulticenter observational study
Primary study designObservational
Secondary study designCase-control study
Study setting(s)GP practice
Study typeScreening
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleInfluence of Active awareness about Venous ThromboEmbolism relevance and Rate of Symptomatic deep vein thrombosis: an observational study
Study acronymAVTERS
Study objectivesAn increase in public awareness would result in an increase in the frequency of objectively confirmed deep vein thrombosis (DVT), wherever its anatomic location.
Ethics approval(s)Bioethics Committee, National TB and Lung Diseases Research Institute, Warsaw, Poland, 19/11/2007, ref: KE-142/2007
Health condition(s) or problem(s) studiedDeep vein thrombosis (DVT)
InterventionA campaign to raise public awareness of DVT was conducted in an urban population cluster (A) of approximately 100,000 via distribution of brochures four times during a year and publishing posters and newsletter articles.

A comparison urban population cluster (B) of approximately 1,574,000, was not exposed to this campaign.

Patients symptomatic for DVT in both populations were referred by general practitioners for a standardized compression ultrasound (CUS) of the whole leg at no charge to the patient. Reports of positive CUS exams documented by photographs were analyzed by an independent adjudication committee blinded to the population cluster. Cluster A was followed for 8 months after the information campaign ended.
Intervention typeOther
Primary outcome measureEvaluation of the impact of an educational campaign dedicated to thromboembolic complications on increased number of correctly diagnosed DVT
Secondary outcome measures1. Evaluation of the rate of correctly diagnosed DVT among the general population in Poland
2. Evaluation of the risk factors in patients with confirmed DVT
3. Evaluation of which diagnostic methods are applied to confirm DVT symptoms
Overall study start date01/12/2007
Completion date30/11/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants3000
Key inclusion criteria1. Male or female aged > 18
2. A patient with clinical symptoms suggesting thrombosis, referred by primary care physicians selected to the study
3. A patient with deep vein thrombosis confirmed with diagnostic methods
4. A patient with newly diagnosed deep vein thrombosis or with recurring thrombosis in a vein with existing thrombosis process
Key exclusion criteria1. Aged under 18
2. No signs or symptoms of deep vein thrombosis
3. No consent for participation in the study
Date of first enrolment01/12/2007
Date of final enrolment30/11/2009

Locations

Countries of recruitment

  • Poland

Study participating centre

Instytut Gruzlicy i Chorob Pluc
Warsaw
01-138
Poland

Sponsor information

Sanofi-Aventis (Poland)
Industry

Bonifraterska Str. 17
Warsaw
00-203
Poland

Website http://www.sanofi-aventis.pl/

Funders

Funder type

Industry

Sanofi-Aventis (Poland)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

25/05/2017: Plain English summary added.